Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cardiovascular drugs and COVID‐19 clinical outcomes: a systematic review and meta‐analysis of randomized controlled trials
Innocent G. Asiimwe, Sudeep Pushpakom, Richard M. Turner, et al.
British Journal of Clinical Pharmacology (2022) Vol. 88, Iss. 8, pp. 3577-3599
Open Access | Times Cited: 10

Showing 10 citing articles:

Global landscape of COVID-19 research: a visualization analysis of randomized clinical trials
Sa’ed H. Zyoud
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Does aspirin have an effect on risk of death in patients with COVID-19? A meta-analysis
Shaodi Ma, Wanying Su, Chenyu Sun, et al.
European Journal of Clinical Pharmacology (2022) Vol. 78, Iss. 9, pp. 1403-1420
Open Access | Times Cited: 17
Overreactive macrophages in SARS-CoV-2 infection: The effects of ACEI
Dominik Felkle, Katarzyna Zięba, Konrad Kaleta, et al.
International Immunopharmacology (2023) Vol. 124, pp. 110858-110858
Open Access | Times Cited: 8
Effect of antiplatelet therapy after COVID-19 diagnosis: A systematic review with meta-analysis and trial sequential analysis
Hong Duo, Mengying Jin, Yanwei Yang, et al.
PLoS ONE (2024) Vol. 19, Iss. 2, pp. e0297628-e0297628
Open Access | Times Cited: 1
Impact of prior antihypertensive treatment on COVID-19 outcomes, by active ingredient
Rosa María García-Álvarez, Maruxa Zapata‐Cachafeiro, Irene Visos‐Varela, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 3, pp. 1805-1815
Open Access | Times Cited: 1
The risk of common hypoglycemic and antihypertensive medications and COVID-19: A 2-sample Mendelian randomization study
Ya Wang, Kai Li, Jiaxing Zeng, et al.
Medicine (2024) Vol. 103, Iss. 6, pp. e36423-e36423
Open Access
Systematic review of Mendelian randomization studies on antihypertensive drugs
Bohan Fan, Junmeng Zhang, Jie Zhao
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access
COVID-19-associated phlebopathy as a current problem of modern phlebology
V. Yu. Bogachev, Б. В. Болдин, P. Yu. Turkin, et al.
Ambulatornaya khirurgiya = Ambulatory Surgery (Russia) (2022) Vol. 19, Iss. 2, pp. 13-20
Open Access | Times Cited: 3
Regional moderate hyperthermia for mild-to-moderate COVID-19 (TherMoCoV study): a randomized controlled trial
Javier Mancilla-Galindo, Ashuin Kammar‐García, María de Lourdes Mendoza-Gertrudis, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 1
Page 1

Scroll to top